S'
Shouryadeep 'Deep' Srivastava, MD, PhD
Senior Vice President of Clinical Development
Actym TherapeuticsTherapeutic Areas
Actym Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| ACTM-838 | Advanced Solid Tumors | Phase 1a/1b |
Senior Vice President of Clinical Development
Actym Therapeutics| Drug | Indication | Phase |
|---|---|---|
| ACTM-838 | Advanced Solid Tumors | Phase 1a/1b |